WallStreetZenWallStreetZen

NASDAQ: OVID
Ovid Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Ovid Therapeutics earnings were -$29.7M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest OVID earnings report on Jun 30, 2024 announced Q2 2024 earnings of $8.5M, down 172.9% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, OVID reported annual earnings of -$52.3M, with -3.4% growth. The next OVID earnings date is Nov 1, 2024.

OVID earnings history

Current Revenue
$567.5k
Current Earnings
-$29.7M
Current Profit Margin
-5,241.5%

OVID Return on Equity

Current Company
-33.4%
Current Industry
22.8%
Current Market
33.7%
OVID's Return on Equity (-33.4%)... subscribe to Premium to read more.
High Return on Equity Performance

OVID Return on Assets

Current Company
-22.9%
Current Industry
3.5%
OVID is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when OVID announces earnings.

OVID Return on Capital Employed

Current Company
-28.61%
Current Industry
21.3%
OVID's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OVID vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OVID-$28.12M-$29.75MN/A-$0.43
SLS-$33.91M-$34.44MN/A-$0.92
CMRX-$84.71M-$84.70MN/A-$0.96
ALXO-$168.93M-$171.44MN/A-$3.63
VTGN-$32.61M-$33.19MN/A-$1.48
View Top Biotech Stocks

OVID earnings dates

Next earnings date
Nov 1, 2024

Ovid Therapeutics Earnings Reports & History FAQ

What were Ovid Therapeutics's earnings last quarter?

On OVID's earnings call on Invalid Date, Ovid Therapeutics (NASDAQ: OVID) reported Q2 2024 earnings per share (EPS) of $0.12, up 166.67% year over year. Total OVID earnings for the quarter were $8.52 million. In the same quarter last year, Ovid Therapeutics's earnings per share (EPS) was -$0.18.

If you're new to stock investing, here's how to buy Ovid Therapeutics stock.

When does Ovid Therapeutics report earnings?

The next OVID earnings date is Invalid Date. Add OVID to your watchlist to be reminded of Ovid Therapeutics's next earnings date.

Is Ovid Therapeutics profitable or losing money?

As of the last Ovid Therapeutics earnings report, Ovid Therapeutics is currently losing money. Ovid Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$29.75 million, a 39.58% decrease year over year.

What was OVID's earnings growth in the past year?

As of Ovid Therapeutics's earnings date in Invalid Date, Ovid Therapeutics's earnings has grown year over year. OVID earnings in the past year totalled -$29.75 million.

What are Ovid Therapeutics's earnings expectations?

The current EPS estimate for Ovid Therapeutics's earnings report in Invalid Date is -$0.20.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.